Forbes October 31, 2022
Deb Gordon

For Americans on Medicare, it’s open enrollment season, the period each year where you can switch your Medicare Advantage or stand-alone Medicare Part D prescription drug plan if you find something better. But many Medicare enrollees are potentially leaving better coverage on the table because they never shop around to see if better options are available.

According to new research released today from online private health insurance marketplace eHealth, 45% of Medicare beneficiaries have not reviewed their coverage options in the past year and 53% have had the same coverage for three or more years.

More people said they will review their coverage this year than have actually done so to date. In eHealth’s survey of more than 1,000 Medicare...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Medicare, Medicare Advantage, Patient / Consumer, Survey / Study, Trends
Medicare’s Selection Of 15 More Drugs For Price Negotiation Puts Spotlight Back On IRA
How Many Physicians Have Opted Out of the Medicare Program? - 2
MedPAC Members Vote to Recommend Pay Hikes for Physicians and Hospitals
Opinion: Former Trump health official: Medicare should cover Wegovy — but not negotiate its price
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.

Share This Article